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Summary A study was made of the intrinsic radiosensitivity of 140 biopsy and surgical specimens of malignant head and neck tumours of
different histologies. Using a soft-agar clonogenic assay, the material was assessed forthe ability to grow in culture (colony-forming efficiency;
CFE) and inherent tumour radiosensitivity (surviving fraction at 2 Gy, SF2). The success rate for obtaining growth was 74% (104/140) with a
mean CFE of 0.093% (median 0.031) and a range of 0.002-1.3%. SF2 was obtained for 88 of 140 specimens, representing a success rate of
63% with a mean SF2 of 0.48 (median 0.43) and a range of 0.10-1.00. There were no significant differences in radiosensitivity between
different sites of the head and neck region. There were no significant relationships between SF2 and disease stage, nodal status, tumour
grade, patient age, primary tumour growth pattern and CFE. The results were compared with those for other tumour types previously
analysed with the same assay. The distribution of the SF2 values for the head and neck tumours was similar to that for 145 cervix carcinomas
and there was no significant difference in mean radiosensitivity between the two tumour types. Also, there was no significant difference in
radiosensitivity between head and neck tumours and either breast or colorectal cancers. However, a group of eight lymphomas was
significantly more radiosensitive. These results confirm the feasibility of carrying out radiosensitivity measurements using a soft-agar
clonogenic assay on head and neck tumours. In addition, the work has shown that radiosensitivity is independent of many clinical parameters
and that the mean value is similar to that reported for cervix carcinomas.
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The probability of achieving local control for patients undergoing
radical radiotherapy has traditionally been said to depend on the
'Rs' ofradiobiology: namely, repair ofsublethal damage, reassort-
ment of cells within the cell cycle, repopulation, reoxygenation
and the inherent tumourradiosensitivity. Focusing on the last para-
meter the surviving fraction at 2 Gy (SF2) of human tumour cell
lines has been shown to correlate with the radioresponsiveness of
the tumour types from which they were derived (Deacon et al,
1984; Fertil and Malaise, 1985). The predictive value of parame-
ters of the low-dose region of radiation cell survival curves has
also been confirmed by studies on experimental animal tumours
(Bristow and Hill, 1990) and in mathematical modelling systems
(Tucker and Thames, 1989). These observations have given rise to
a strong and growing interest in clinical radiobiological measure-
ments of inherent radiosensitivity directly on human tumours to
predict radiocurability (West, 1995).
Few large prospective studies carried out on primary tumours
have evaluated the predictive value of SF2 measurements for
radiotherapy outcome. The cell adhesive matrix (CAM) assay has
been used by two groups to evaluate tumour radiosensitivity in
head and neck cancers. For patients treated with post-operative
radiotherapy, SF2 was not predictive of treatment outcome
(Brock et al, 1990, 1992). However, in a study in which the
majority of patients were treated with radiotherapy alone, tumour
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radiosensitivity was a significant prognostic factor (Girinsky et al,
1993, 1994). Work using a soft-agar clonogenic assay to measure
SF2 on cervical cancers undergoing radical radiotherapy has
shown that tumourradiosensitivity is ahighly significant and inde-
pendent prognostic factor for both local control and overall
survival (West et al, 1993, 1997).
Neither the CAM nor the soft-agar clonogenic assays are suit-
able for routine clinical application. A period of 3 (CAM) or 4
(soft agar) weeks is required to generate data, and success rates in
obtaining results are only around 70%. More rapid assays are
being studied fortheirpotential use in clinical studies: in particular
the calorimetric microtitre (MTT) assay (Ramsay et al, 1992), the
micronucleus assay (Zolzer et al, 1995), fluorescence in situ
hybridization (Coco-Martin et al, 1994) and assays of DNA
double-strand break repair (Zaffaroni et al, 1994; Schwartz et al,
1996). Alongside this interest in evaluating the potential of rapid
assays of tumour radiosensitivity, there is a need to show, within
large prospective clinical studies, whether there is a future for
radiosensitivity testing in cancers treated with radiotherapy alone
or in combination with surgery. In view of the results obtained on
carcinoma of the cervix using a soft-agar clonogenic assay, the
following work was established using the same methods to assess
the ability of SF2 measurements to predict outcome following
radiotherapy for head and neck cancers. Clinically, prediction of
radiocurability is of particular importance in head and neck
oncology because ofits high incidence, the fact that it is generally
a locoregional disease, and that radiotherapy is used on the
majority of patients. In addition, it is a disease for which radio-
therapy and surgery can be competing modalities so that radio-
sensitivity testing could be used to determine the best primary
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been compared with those for other tumour sites assayed using
E ~ E. ..the same method.
~. MATERIALS AND METHODS
i_ * '~ ~~- Specimens
Biopsy and surgical specimens were obtained before treatment
from 140 patients with locoregional carcinomas from different
' ~ sites ofthe head and neck region. The majority ofspecimens (137)
were from primary lesions and three were surgically removed
l el regional neck node metastases. Most of the tumour specimens
1 | _ a (125/140) were histologically classified as squamous cell carci-
S. m 1nomas, and there were five undifferentiated carcinomas, four
adenocarcinomas, two adenoidcystic carcinomas, one neuro-
blastoma, one a transitional cell cancer, one a primitive neuro-
ectodermal tumour and one malignant melanoma. No selection
~ __ > Xcriteria were used according to tumour site of origin or TNM stage
='V~Aj..h~ (Spiessl et al, 1990). No laser resected specimens were included as
the spread of heat to adjacent tissue might have affected the
tumour viability and radiosensitivity.
~~ ~Cell culture
Media formulations (high antibiotic medium for tumour disaggre-
gation and growth medium for tumour culture) and disaggregation
methods have been described previously (Davidson et al, 1990).
The specimens were processed either fresh or after cryopreserva-
tion in liquid nitrogen. Before disaggregation the fresh specimens
were stored in the dark at 4'C for 12-24 h in basal Eagle's medium
gen,plus 20% fetal calf serum supplemented with 10 gtg ml-'
I Photomicrogaphs of malignant (A) and fibroblast (B) colonies gentamycin, 10~tg ml-' amphotericin, 50 IU ml-' penicillin,
in soft agar at x 100 and x 40 magnification respectively (original 50Rtg ml-' streptomycin and 7 mm of Hepes buffer.
,ation) Single-cell suspensions were cultured in vitro using a soft-agar
assay to obtain values for colony-forming efficiency (CFE) and
SF,. Irradiation of the tumour single-cell suspensions was carried
out using a caesium-137 or cobalt-60 source with a dose rate of 3.7
o - 3 and 1-1.5 Gy min-' respectively. The cultures were grown in a
0 * _0gtr- humidified 5% CO2 and 5% 0° atmosphere at 37°C and fed
°10 * weekly. After 4 weeks the colonies were stained for 24 h using p-
1* iodonitrotetrazolium violet before fixation in 4% formaldehyde.
;° Colonies with a diameterexceeding 60gim, corresponding to more
than 50 cells, were counted under a light microscope using an
o0 ocular ruler or a videoplan image analysis system providing statis-
tics of colony diameters as described previously (Davidson et al,
'0 Cervix 1990). Cytospins stained with May-Grunwald-Giemsa were
- Lymphoma prepared from all tumour specimens, thereby allowing for
0 4 A Colorectal confirmation of the presence and fraction of malignant and non-
* Head and neck malignant cells. For immunohistochemical characterization of the
0.0 0.2 0.4 0.6 0.8 1.0 colonies, agar pellets from a number of successfully grown
SF2 tumours were wrapped up in lenspaper, dehydrated in alcohol,
embedded in paraffin, sectioned and stained with antibodies
2 Cumulative frequency distribution of SF values for head and against vimentin (Clone V 9, Dako) and low molecular weight
nours (n = 88), carcinomas of the cervix (n = 145), colorectal cancers
and lymphomas (n = 8) cytokeratins (CAM 5.2, Becton Dickinson).
treatment. This report represents the preliminary analysis of data
obtained over a period of 5 years and is the first published study to
have examined head and neck tumour radiosensitivity on primary
material using a soft-agar clonogenic assay. The results have
Statistical analysis
The Mann-Whitney U-test was used to test for the level of signifi-
cance between independent variables. Spearman's rank correlation
was used to examine the relationship between different parame-
ters. The Kruskal-Wallis one-way analysis of variance was used to
British Journal of Cancer (1998) 77(12), 2371-2375
2372 TBjork-Eriksson et al
C, c)
a)
0-
a)
.Ca ct
Figure 2
neck tun
(n=65)
0 Cancer Research Campaign 1998Radiosensitivity ofheadandneck cancers 2373
0.8-
0.6
0.4 z1] 0.4-
IL
0.2
0.0
0.0
S r=0.013, P=0.91
0 0
S
* *0* * 0
S. sSf ¶. * # 3*S
0
0.2 0.4 0.6 0.8 1.0
SF2
1.0-
0.8-
0.6-
CD)
0.4-
0.2-
1
S
0
0
0
0
0
0
I
I
1
A.
S
S
,or
S
S
S
0
S 0
S
S
S
Ti
0
S
0
S
O.OJ Oral Orophx Nasophx Hypophx Larynx Sinonasal
Figure 4 Tumour radiosensitivity (SF2) as a function of tumour site within
the head and neck region. Bars indicate mean values
Figure 3 The lack of correlation between tumour radiosensitivity (SF2) and
colony-forming efficiency (CFE) for head and neck tumours (n = 88)
Table 1 Values for SF2 vs tumour grade and growth pattern
Grade n Mean ± s.d. Median SF2 Range
All SCC 77 0.49±0.24 0.43 0.10-1.00
Poor 25 0.50 ± 0.25 0.40 0.17-0.99
Moderate 30 0.43±0.22 0.40 0.10-0.90
Well 8 0.46 ± 0.17 0.41 0.30-0.80
Exophytic 20 0.50 ± 0.24 0.41 0.20-0.94
Ulcerative 21 0.46 ± 0.21 0.46 0.10-0.80
SCC, squamous cell carcinoma.
Table 2 Values for SF2 vs tumour UICC T-stage
T-stage n Mean ± s.d. Median Range
1 2 0.64 ± 0.01 0.64 0.58-0.70
2 10 0.50 ± 0.24 0.37 0.30-0.90
3 17 0.38±0.16 0.32 0.13-0.77
4 41 0.50 ± 0.25 0.44 0.10-1.00
Table 3 Values for SF2 vs tumour UICC N-stage
N-stage n Mean ± s.d. Median Range
0 40 0.47± 0.23 0.40 0.13-0.10
1 7 0.40± 0.19 0.33 0.20-0.70
2 17 0.45 ± 0.25 0.40 0.10-0.99
3 6 0.60 ± 0.25 0.54 0.30-1.00
test for differences in radiosensitivity between groups. A signifi-
cance level of0.05 was used throughout.
RESULTS
Colony morphology
As there have been studies that have reported the growth of fibro-
blasts in soft-agar clonogenic assays (Lawton et al, 1994;
Stausbol-Gron et al, 1995), care was taken to ensure that only
colonies arising from malignant cells were scored. Colonies oftwo
different morphological types were identified (Figure 1). The
majority of the colonies were homogenous, tightly packed with
round identical cells and with a colony diameter of approximately
60-200 gm. The malignant epithelial origin of these colonies was
confirmed by staining with a low molecular weight cytokeratin
marker (CAM 5.2). These colonies were counted as tumour cell
colonies. A small and varying number (approximately 0-10%) of
large, loose and star-shaped colonies was also seen. These colonies
all stained positively with vimentin antibodies (Clone V 9) and
were considered to represent fibroblast growth. Colonies with this
appearance were not counted in the experiments. There were no
difficulties in distinguishing between the two colony types
according to their number and appearance.
Success rate
A total of 104 out of 140 specimens (74%) were grown success-
fully with a mean ± standard deviation CFE of0.093 ± 0.17% and
a range of 0.0020-1.30%. Nineteen experiments became infected
and 17 specimens failed to grow. The mean proportion of malig-
nant cells in cell suspensions prepared from the biopsies was 56%
with a wide range from 5% to 95%. The mean proportions of
macrophages and inflammatory cells were 18% and 26%, ranging
from 2% to 60% and 2% to 90% respectively. There were no
significant relationships between CFE and the percentages of the
different cell types in cell suspensions (P > 0.22).
SF2
SF2 values were obtained for 88 out of 140 specimens (63%) with
a mean ± standard deviation of 0.48 + 0.025 and a range of
0.10-1.00. A cumulative frequency histogram ofall 88 SF2 values
is shown in Figure 2. There was no significant relationship
between tumour SF2 and CFE (Figure 3) and patient age (P =
0.71). Information on tumour grade was available for 63 squamous
cell carcinomas (Table 1). There were 25 poor, 30 moderate and
eight well-differentiated tumours. There was no significant rela-
tionship between tumour grade and SF2(P > 0.49). For 41 of the
squamous cell carcinomas, description of tumour growth pattern
was available (Table 1). There was no significant difference in the
radiosensitivity of exophytic and ulcerative tumours (P = 0.58).
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Table 4 Values for SF2 vs tumour site within the head and neck region
Site n Mean ± s.d. Median Range
Oral cavity 28 0.54 ± 0.22 0.49 0.24-1.00
Oropharynx 25 0.44 ± 0.25 0.40 0.10-1.00
Nasopharynx 5 0.42 + 0.11 0.43 0.28-0.53
Hypopharynx 5 0.34 ± 0.19 0.30 0.17-0.66
Larynx 11 0.51 +0.25 0.46 0.13-0.98
Sinonasal 9 0.48 + 0.27 0.40 0.20-0.94
Table 5 Values for SF2 vs tumour type
Tumour n Mean ± s.d. Median Range
Colorectal 65 0.48 + 0.021 0.45 0.20-0.83
Head and neck 88 0.48 ± 0.025 0.43 0.10-1.00
Cervix 145 0.44+ 0.015 0.41 0.13-0.93
Lymphoma 8 0.30 ± 0.019 0.32 0.22-0.36
Breast 3 0.24 + 0.090 0.22 0.10-0.41
For the squamous cell carcinomas an examination was made of
tumour radiosensitivity in relation to T and N stage (Tables 2 and
3). No significant relationships were found (P > 0.54). An exami-
nation was also made of the radiosensitivity of different tumour
sites within the head and neck region (Figure 4). Using the
Kruskal-Wallis test there was no significant difference in
radiosensitivity between the different tumour sites within the head
and neck region (Table 4, P = 0.23).
The mean SF, for all 88 head and neck tumours was 0.48. This
was compared with data available for other tumour types studied
using the same assay (Table 5, Figure 2). There was no significant
difference in the radiosensitivity of head and neck, cervix,
colorectal and breast tumours. However, the lymphomas were
significantly more radiosensitive than head and neck (P = 0.03),
cervix (P = 0.02) and colorectal (P = 0.003) tumours. Using the
Kruskal-Wallis test significant differences were seen in the
radiosensitivity ofdifferent tumour types (P = 0.013).
DISCUSSION
Radical radiotherapy of malignant head and neck tumours has a
possible advantage over surgery of less cosmetic and functional
loss. If, however, radical radiotherapy fails, subsequent potentially
curative therapy in the form of surgery will have been delayed and
possibly made more complicated. Prediction of the individual
outcome of the radiotherapy schedule is therefore important for
suggesting alternative or more aggressive treatment. Repopulation
of clonogenic cells during the treatment period, tumour hypoxia
and the number of clonogenic cells are all biological factors with
a potential to affect the outcome of fractionated external beam
radiotherapy and should be considered as candidates for predictive
tests. However, intrinsic radiosensitivity expressed as parameters
of the low-dose region of radiation cell survival curves is thought
to be one of the most important and significant factors determining
the response of a tumour to radiation treatment (Deacon et al,
1984; Fertil and Malaise, 1985; Tucker and Thames, 1989; Brock
et al, 1990, 1992; Davidson et al, 1990; West and Hendry 1992;
West et al, 1993, 1997; Girinsky et al, 1993, 1994).
In this study an examination has been made of the radiosensi-
tivity of head and neck cancers using a clonogenic assay. We have
shown that in vitro growth of tumours from the head and neck
region can be achieved using a soft-agar assay. The culturing
success rate was 74% and SF, was obtained for 63% ofall patients
biopsied. The latter figure is similar to the 60% success rate
reported by Brock et al (1990) for primary head and neck carci-
nomas using the CAM assay. Girinsky et al (1993) reported a
success rate for obtaining SF, values in head and neck cancers
using the CAM assay of75% when the cell yield was high enough
to allow cell cultures to be set up. Using the same criteria we also
obtained a success rate of74% in obtaining SF, measurements.
Using a soft-agar assay, tumour cells grow as spherical colonies in
an agar layer while the growth of cells that require anchorage to a
solid substrate such as fibroblasts is inhibited. However, there have
been reports recently that have shown that fibroblasts can grow in
soft agar(Parkins and Steel, 1990; Lawton et al, 1994; Stausbol-Gron
et al, 1995). In the present study, fibroblast growth was not inhibited
as a small number of large, star-shaped and vimentin-positive
colonies was identified. No difficulties were found in the discrimina-
tion of such colonies and tumour. Unfortunately fibroblast colony
numbers were too small to allow determination offibroblast SF, and
the colonies were all excluded in this study.
Other assays for measuring radiosensitivity are being investi-
gated to increase both the assay time and success rate (see intro-
duction) but none are suitable yet for routine clinical application.
To date the strongest correlation between tumour radiosensitivity
measurements and clinical outcome has been achieved using a
soft-agar assay on cervix tumours treated with radical radiotherapy
(West et al, 1993, 1997). Girinisky et al (1993, 1994) also reported
a significant but less strong relationship using the CAM assay in
head and neck tumours treated predominantly with radiotherapy
alone. It may be that by using a soft-agar assay a significant rela-
tionship might be found between tumour radiosensitivity and clin-
ical outcome for cancers treated with post-operative radiotherapy.
Therefore, despite the fact that Brock et al (1992) failed to show a
relationship between tumour radiosensitivity measured using the
CAM assay and clinical outcome in patients treated with radio-
therapy plus surgery, there is interest in repeating his study using a
soft-agar clonogenic assay. As soon as we have adequate follow-
up, we will report on the correlation between SF, and outcome.
Using a soft-agar assay our mean value for the radiosensitivity
of head and neck cancers was higher than those reported using the
CAM assay (Brock et al, 1990; Girinsky et al, 1994) and this prob-
ably reflects differences between the two assays. The radiosensi-
tivites of the head and neck cancers studied were variable (SF2
from 0.10 to 1.00). The latter observation supports the idea that a
predictive assay based on tumour SF, measurements might be
useful in head and neck cancers. In addition, we have found that
the radiosensitivity of head and neck cancers is independent of
many clinical parameters, i.e. stage, nodal status and patient age,
and this confirms the findings of others (Brock et al, 1992;
Girinsky et al, 1993, 1994). This study also confirmed the finding
that there are no significant differences in mean radiosensitivity
for tumours of different sites within the head and neck region
(Girinsky et al, 1993; Pekkola-Heino et al, 1995). The latter obser-
vation, however, is in contrast to a report by Brock et al (1992),
who found that oral cavity tumours were more radioresistant than
carcinomas of the larynx, an observation that is consistent with
clinical observations (Corv6 et al, 1994). Primary tumour growth
pattern scored as exophytic or ulcerating is clinically believed to
represent different degrees of tumour oxygenation. We found no
relationship between tumour radiosensitivity and growth pattern.
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We also found no relationship between tumourradiosensitivity and
CFE, which confirms previous findings in a number of different
tumour types (West et al, 1991; Girinsky et al, 1994).
This study has also shown that head and neck and cervix
tumours have similar radiosensitivity as reported by Girinsky et al
(1993) using the CAM assay. Previous studies have suggested that
there may be differences in the radiosensitivity ofprimary tumours
(Rofstad et al, 1987; Brock et al, 1989). However, for the first
time, we report that there are significant differences in the
radiosensitivity of different tumour types that can be measured in
primary cultures without establishing cell lines.
The ultimate aim ofthis study is to correlate the radiosensitivity
data with clinical outcome for a tumour type in which radiosensi-
tivity could have a clear role to play in determining the optimum
primary treatment (surgery/radiotherapy). This will require
adequate follow-up, a minimum of 2 years, for all the patients
studied and will be carried out in the future. However, as there is a
lack ofclinical measurements ofradiosensitivity in primary human
tumours, our preliminary data are presented here. This work has
shown the feasibility ofmeasuring head and neck cancer radiosen-
sitivity using a soft-agar clonogenic assay and that using this assay
the radiosensitivity is independent of many clinical features and is
similar to that of cervix carcinomas. In addition, we have shown,
in primary tumours, that cancers differ significantly in intrinsic
radiosensitivity.
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